Hemenway Trust CO LLC Bristol Myers Squibb CO Transaction History

Hemenway Trust CO LLC

$1.12 Billion
Q2 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$47.98 - $54.4 $36,224 - $41,072	-755 Reduced 16.45%	3,835 $207,000
Q4 2023 Feb 12, 2024	SELL	$48.48 - $57.85 $97,881 - $116,799	-2,019 Reduced 30.55%	4,590 $235,000
Q3 2023 Nov 13, 2023	SELL	$57.89 - $64.73 $52,679 - $58,904	-910 Reduced 12.1%	6,609 $383,000
Q2 2023 Aug 11, 2023	SELL	$63.71 - $70.74 $24,273 - $26,951	-381 Reduced 4.82%	7,519 $480,000
Q1 2023 May 10, 2023	SELL	$65.71 - $74.53 $4,928 - $5,589	-75 Reduced 0.94%	7,900 $547,000
Q4 2022 Feb 08, 2023	SELL	$68.48 - $81.09 $5,546 - $6,568	-81 Reduced 1.01%	7,975 $573,000
Q3 2022 Nov 08, 2022	SELL	$0.13 - $76.84 $3 - $1,921	-25 Reduced 0.31%	8,056 $573,000
Q2 2022 Jul 19, 2022	SELL	$72.62 - $79.98 $7,262 - $7,998	-100 Reduced 1.22%	8,081 $622,000
Q1 2022 May 16, 2022	SELL	$61.48 - $73.72 $104,208 - $124,955	-1,695 Reduced 17.16%	8,181 $597,000
Q4 2021 Feb 08, 2022	SELL	$53.63 - $62.52 $509,163 - $593,564	-9,494 Reduced 49.01%	9,876 $616,000
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $56,507 - $66,191	-955 Reduced 4.7%	19,370 $1.15 Million
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $328,370 - $357,595	-5,304 Reduced 20.7%	20,325 $1.36 Million
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $208,936 - $234,991	-3,521 Reduced 12.08%	25,629 $1.62 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $235,463 - $266,823	4,078 Added 16.27%	29,150 $1.81 Million
Q3 2020 Oct 28, 2020	BUY	$57.43 - $63.64 $416,367 - $461,390	7,250 Added 40.68%	25,072 $1.51 Million
Q2 2020 Jul 28, 2020	BUY	$54.82 - $64.09 $264,067 - $308,721	4,817 Added 37.04%	17,822 $1.05 Million
Q1 2020 May 07, 2020	SELL	$46.4 - $67.43 $92,104 - $133,848	-1,985 Reduced 13.24%	13,005 $725,000
Q4 2019 Jan 15, 2020	BUY	$49.21 - $64.19 $737,657 - $962,208	14,990 New	14,990 $962,000
Q3 2018 Oct 15, 2018	SELL	$55.19 - $62.25 $227,934 - $257,092	-4,130 Closed	0 $0
Q2 2018 Jul 30, 2018	SELL	$50.53 - $62.98 $369,626 - $460,698	-7,315 Reduced 63.91%	4,130 $229,000
Q1 2018 Apr 24, 2018	BUY	$59.92 - $68.98 $29,960 - $34,490	500 Added 4.57%	11,445 $724,000
Q4 2017 Feb 02, 2018	SELL	$59.94 - $65.35 $899 - $980	-15 Reduced 0.14%	10,945 $671,000
Q3 2017 Oct 26, 2017	BUY	$55.23 - $63.74 $605,320 - $698,590	10,960	10,960 $699,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

Vanguard Group Inc Valley Forge, PA

187M
Shares

$9.92 Billion
0.15% of portfolio
Black Rock Inc. New York, NY

159M
Shares

$8.44 Billion
0.15% of portfolio
State Street Corp Boston, MA

91.4M
Shares

$4.86 Billion
0.17% of portfolio
Jpmorgan Chase & CO New York, NY

74.6M
Shares

$3.97 Billion
0.27% of portfolio
Charles Schwab Investment Management Inc San Francisco, CA

59.1M
Shares

$3.14 Billion
0.47% of portfolio

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemenway Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hemenway Trust CO LLC with notifications on news.

Account